Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

This new course ran for the first time in January 2019, with an engaging and thought-provoking programme of talks, tours of facilities and group discussions. Feedback from participants was uniformly excellent. Applications for the January 2020 course open on 15th August 2019.

Copyright © Oxford University Images / Greg Smolonski

The Oxford Short Course in Experimental Medicine for Mental Health (OxCEMM) provides a practical and comprehensive grounding in experimental medicine for mental health. It is aimed at those with a basic understanding, either at early stages in research, or planning to be actively involved in the future.

Are you aware of experimental medicine as an approach, but unsure how to begin your own study? Or are you supporting colleagues working on experimental medicine research projects, but unsure about the bigger picture?

The OxCEMM course is open to clinical and pre-clinical staff and trainees, and medical doctors at any career stage. It will be of interest to psychiatrists, neurologists, GPs and other specialists, nurses, basic scientists, allied health professionals and pharmacists.

 

OxCEMM 2020 promises to be an excellent opportunity to learn and improve skills and understanding of experimental medicine for mental health. Participants in the last course were engaged and enthusiastic. Even those who were already running experimental medicine studies said how much they had learnt and how useful it was to have all the practical information they need in a single place.

- Associate Professor, Liz Tunbridge, NIHR Oxford Health Training Lead.

 

There are limited places and bursaries available. Bursaries will cover the costs of the course, accommodation, evening/daytime meals, as well as, refreshments and they will be awarded by the NIHR Oxford Health Biomedical Research Centre.

 

Immensely useful. Thank you so much for organising an intellectually stimulating course filled with inspirational content and pragmatic advice.
- OxCEMM 2019 participant.

 

 

 

 

 

 

 

 

 

For more information or to request an alert when applications open on 15th August for OxCEMM January 2020, please email oxcemm@psych.ox.ac.uk.

Course Brochure

Apply NOW 

 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Just Over Half of British Indians Would Get COVID Vaccine

COVID-19 Mental Health

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

Mental Health Schizophrenia

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental Mental Health Worse Since New National Restrictions

COVID-19 Child and adolescent Early intervention Mental Health Psychological therapy

Parental stress, depression, and anxiety have again increased since new national restrictions have been introduced according to the latest report from the Oxford University led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study based on data from over 6000 UK parents.

Potential New Target to Prevent or Delay Dementia

Alzheimer's disease Dementia Mental Health Old-age psychiatry

New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.

SSRI Treatment in Young People with Depression and Anxiety

Anxiety Depression Mental Health

Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.

Collaborating with Youth is Key to Studying Mental Health Management

Anxiety Depression Mental Health

The Global Mental Health Databank, a feasibility study, hopes to enable youth from the United Kingdom, South Africa, and India to work directly with mental health researchers to better understand how young people can manage their own mental health.